Masaru Samura

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

David Ishola, Daniela Manno, Muhammed O. Afolabi et al. · The Lancet Infectious Diseases · 2021 · 95 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

Muhammed O. Afolabi, David Ishola, Daniela Manno et al. · The Lancet Infectious Diseases · 2021 · 93 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Support for fungal infection treatment mediated by pharmacist-led antifungal stewardship activities

Masaru Samura, Naoki Hirose, Takenori Kurata et al. · Journal of Infection and Chemotherapy · 2019 · 27 citations

Pharmacy, Clinical Pharmacy, Pharmacotherapy +14

Relationship between nephrotoxicity and area under the concentration–time curve of vancomycin in critically ill patients: a multicenter retrospective study

Tomoyuki Ishigo, Kazuaki Matsumoto, Hiroaki Yoshida et al. · Microbiology Spectrum · 2024 · 20 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Model‐informed precision dosing of vancomycin for rapid achievement of target area under the concentration‐time curve: A simulation study

Kazutaka Oda, Tomoyuki Yamada, Kazuaki Matsumoto et al. · Clinical and Translational Science · 2023 · 19 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +17